id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2007-N-0475-0040,FDA,FDA-2007-N-0475,"Response Letter from Office of the Commissioner Acting Chief Scientist to FDA/CDER and Shire Development, Inc., re Midodrine Amendment August 25, 2014",Other,Letter(s),2014-09-19T04:00:00Z,2014,9,2014-09-19T04:00:00Z,,2014-09-19T12:52:35Z,,0,0,090000648187ddc9
FDA-2007-N-0475-0039,FDA,FDA-2007-N-0475,"Amendment to Joint Agreement from FDA/CDER and Shire Development, Inc. to the FDA Commissioner  re Midodrine Amendment August 25, 2014",Other,Memo,2014-08-26T04:00:00Z,2014,8,2014-08-26T04:00:00Z,,2014-08-26T18:14:47Z,,0,0,0900006481846556